Home / Companies / News / NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine

NPPA allows 50% price hike for ibuprofen, ranitidine, carbamazepine

These are scheduled drugs (or ones that are under price control) and low priced

drugs, pharma, prices, drug prices, medicines, health

Premium

Some of the companies that stand to benefit by the move are Torrent Pharmaceuticals, Cadila Pharmaceuticals, Zydus Cadila, and J B Chemicals as they have top-selling ranitidine brands | Illustration: Binay Sinha

Sohini Das Mumbai

4 min read Last Updated : Jul 03 2021 | 2:18 AM IST

India’s pharmaceutical pricing regulator has allowed a one-time price hike of 50 per cent for three key drugs -- ibuprofen (analgesic), ranitidine (antacid), and carbamazepine (epilepsy) -- that are used as the first line of treatment.

These are scheduled drugs (or ones that are under price control) and low priced. After the latest increase, the price of carbamazepine would range from Rs 1 to Rs 4.61 per tablet, depending on the dosage; for ranitidine, the new price would be in the range of Rs 1-2.43 per tablet or per ml of liquid; for ibuprofen, it would be 59 paise to Rs

Topics : Coronavirus NPPA Pharma industry drugs Drug prices Torrent Pharma Zydus Cadila GSK Pharma Sun Pharma

What you get on BS Premium?

Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
Pick your 5 favourite companies, get a daily email with all news updates on them.
Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
Preferential invites to Business Standard events.
Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.

VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in